TripSit · AB-FUBINACA

正文中文为机器翻译，仅供参考；专业内容以折叠的原文为准。

详情

别名

ab-fub

分类

research-chemical 习惯形成 tentative 常规

剂量

口服

常规

0.5-1.5mg

重剂量

3mg+

轻度

0.25-0.5mg

强效

1.5-3mg

Vapourized

常规

0.5-1.5mg

重剂量

3mg+

轻度

0.25-0.5mg

强效

1.5-3mg

效应

Euphoric stimulating high increases creativity and appetite short-term memory deficits similar to cannabis

相关链接

经验报告

https://www.erowid.org/experiences/subs/exp_ABFUBINACA.shtml

名称

ab-fubinaca

通用名

AB-FUBINACA

属性

后遗效应

Vapourized: 1–2 小时 | Oral: 2–10 小时

别名

ab-fub

分类

research-chemical 习惯形成 tentative 常规

剂量

Vapourized Light: 0.25-0.5mg Common: 0.5-1.5mg Strong: 1.5-3mg Heavy: 3+mg | Oral Light: 0.25-0.5mg Common: 0.5-1.5mg Strong: 1.5-3mg Heavy: 3+mg

持续

Vapourized: 1–2 小时 | Oral: 5–15 小时

效应

Euphoric, stimulating high, increases creativity and appetite, short-term memory deficits, similar to cannabis

起效

Vapourized: 1–5 分钟 | Oral: 30–240 分钟

摘要

Arguably the most common synthetic cannabinoid, AB-FUBINACA was originally developed by Pfizer as an analgesic, but has since abandoned for medical use. It has since found a following in the RC community, however it's extremely high potency and inclusion in synthetic blends makes it dangerous, and it has killed in overdose. Exercise caution.